Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Biogen Idec to Present at the 31st Annual J.P. Morgan Healthcare Conference

  Biogen Idec to Present at the 31st Annual J.P. Morgan Healthcare Conference

JPMorgan Healthcare Conference 2013

Business Wire

WESTON, Mass. -- January 2, 2013

Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the
31^st Annual J.P. Morgan Healthcare Conference. The webcast will be live on
Monday, January 7, 2013 at 2:30 p.m. PT, 5:30 p.m. ET. To access the live
webcast, please visit Biogen Idec’s Investors section at
An archived version of the webcast will be available for 14 days following the

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and
delivers to patients worldwide innovative therapies for the treatment of
neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in
1978, Biogen Idec is the world’s oldest independent biotechnology company.
Patients worldwide benefit from its leading multiple sclerosis therapies, and
the company generates more than $5 billion in annual revenues. For product
labeling, press releases and additional information about the company, please


Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations
Sponsored Links
Sponsored Links